GeminIQ Website Logo

Viewing SIBN free

Subscribe for full history, 90+ metrics, screener, watchlist...

SI-BONE, Inc.

SIBN

Subscribe to unlock 17+ years of data

Financial Statements

Values in Millions ($)
2026-06-30
2026-03-31
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Financial statements beyond 3 years are for subscribers only.

Unlock 17+ years of income statements, balance sheets, and cash flow statements

Start 7-day free trial
Subscriber-only column
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value
333442263441353026323353
Debt Securities Available For Sale Excluding Accru…
113111106119111103115121126126133113
Accounts Receivable Net Current
313130272427272525222220
Inventory Net
383634363430272623212022
Prepaid Expense And Other Assets Current
444333323332
Assets Current
220215216211207204208204202204211211
Property Plant And Equipment Net
222021222221202119171616
Operating Lease Right Of Use Asset
771112222233
Other Assets Noncurrent
000000000000
Assets
249243239234231227230227224224230231
Liabilities And Stockhold…
Liabilities Current
Accounts Payable Current
975878677854
Accrued Liabilities Current
151420181615191613121714
Operating Lease Liability Current
011111111111
Liabilities Current
242125262524272522212319
Long Term Debt Noncurrent
363636363635353636363636
Operating Lease Liability Noncurrent
770001111122
Other Liabilities Noncurrent
--0000000000
Liabilities
666461626160636259586157
Stockholders Equity
Preferred Stock Value
000000000000
Common Stock Value
000000000000
Additional Paid In Capital
641633627620614605598591585577569563
Accumulated Other Comprehensive Income Loss Net Of…
011110010000
Retained Earnings Accumulated Deficit
-459-455-450-449-444-438-431-427-420-411-400-389
Stockholders Equity
182179178172170167167165165166169174
Liabilities And Stockholders Equity
249243239234231227230227224224230231
Allowance For Doubtful Accounts Receivable Current
11111111111-
Preferred Stock Par Or Stated Value Per Share
000000000000
Preferred Stock Shares Authorized
555555555555
Preferred Stock Shares Issued
000000000000
Preferred Stock Shares Outstanding
000000000000
Common Stock Par Or Stated Value Per Share
000000000000
Common Stock Shares Authorized
100100100100100100100100100100100100
Common Stock Shares Issued
454444434342424242414140
Shares Outstanding
454444434342424242414140

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Custom Table

0/5
Search a metric to start building a table

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Interactive Financial Visualizations

0/1
Search a metric to start building a visual

Subscribe to unlock 17+ years of data

Earnings Market Reaction

Fiscal Year
Q1 1 Month
Q1 2 Month
Q1 3 Month
Q2 1 Month
Q2 2 Month
Q2 3 Month
Q3 1 Month
Q3 2 Month
Q3 3 Month
Q4 1 Month
Q4 2 Month
Q4 3 Month
202630.23%47.37%52.97%---------
202514.89%12.04%4.86%4.19%-12.19%-3.19%25.51%26.21%5.74%-16.35%-7.85%-7.39%
2024-10.40%-17.54%3.06%16.88%-5.91%-10.90%-13.50%-8.70%7.23%-20.50%-24.89%7.32%
2023---8.55%1.97%-19.20%9.93%22.61%14.31%-14.13%-13.18%-15.99%

Earnings Market Reaction data beyond 3 years is for subscribers only.

Unlock the full earnings market reaction history

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics
2026-06-30
2026-03-31
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Metric history beyond 3 years is for subscribers only.

Unlock 17+ years of history across 90+ calculated metrics

Start 7-day free trial
Subscriber-only column
Liquidity Ratios
Current Ratio
9.15
9.99
8.55
7.97
8.38
8.53
7.66
8.25
9.17
9.76
9.01
10.89
Quick Ratio
7.37
8.17
7.03
6.52
6.87
7.14
6.54
7.12
7.99
8.63
8.01
9.64
Working Capital
195.87M
193.23M
190.84M
184.34M
182.70M
180.25M
180.65M
179.02M
180.27M
182.77M
187.94M
191.65M
Leverage & Debt
Debt to Equity
0.36
0.36
0.34
0.36
0.36
0.36
0.38
0.38
0.36
0.35
0.36
0.33
Interest Coverage TTM
-7.13
-7.80
-8.50
-9.08
-9.18
-9.53
-10.25
-11.95
-12.96
-13.60
-13.56
-13.24
Debt Ratio
0.27
0.26
0.26
0.27
0.26
0.26
0.28
0.27
0.26
0.26
0.26
0.25
Efficiency & Turnover
Asset Turnover TTM
0.89
0.88
0.86
0.84
0.81
0.78
0.73
0.69
0.66
0.77
0.72
0.68
Days Sales Outstanding TTM
47.46
51.03
52.11
48.50
48.43
50.44
53.94
52.18
54.76
56.64
56.01
50.39
Receivables Turnover TTM
7.69
7.15
7.00
7.53
7.54
7.24
6.77
7.00
6.67
6.44
6.52
7.24
Per Share Metrics
Diluted EPS TTM
-0.33
-0.38
-0.44
-0.50
-0.56
-0.63
-0.75
-0.90
-0.99
-1.05
-1.13
-1.08
Free Cash Flow Per Share TTM
-0.18
-0.13
-0.21
-0.08
-0.13
-0.48
-0.55
-0.60
-0.63
-0.56
-0.69
-0.78
Dividend Per Share TTM
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Margin Metrics
Gross Profit Margin TTM
79.53%
79.59%
79.57%
79.62%
79.45%
79.25%
79.03%
77.70%
77.69%
78.10%
78.78%
81.53%
Operating Profit Margin TTM
-8.31%
-9.67%
-11.11%
-13.10%
-14.90%
-17.38%
-21.08%
-26.91%
-30.39%
-33.10%
-33.79%
-34.64%
Net Profit Margin TTM
-6.85%
-8.10%
-9.41%
-11.24%
-12.83%
-15.03%
-18.49%
-23.82%
-27.10%
-29.93%
-31.20%
-32.98%
Growth Metrics
Net Revenue Growth (1Y)
15.30%
16.77%
20.19%
23.27%
22.93%
22.60%
20.37%
18.98%
21.15%
23.46%
30.52%
32.40%
Net Income Growth (1Y)
-38.43%
-37.12%
-38.85%
-41.83%
-41.82%
-38.42%
-28.67%
-14.08%
-14.30%
-21.57%
-29.25%
-32.58%
EPS Growth (1Y)
-40.77%
-39.44%
-40.97%
-43.81%
-43.82%
-40.46%
-33.89%
-17.07%
-21.46%
-33.10%
-37.03%
-42.47%
Valuation Metrics
P/E TTM
-49.61
-33.25
-44.81
-29.22
-33.89
-22.37
-18.81
-15.59
-13.08
-15.54
-18.61
-19.65
P/B TTM
3.98
3.10
4.77
3.69
4.73
3.55
3.48
3.54
3.24
4.05
4.76
4.93
P/S TTM
3.40
2.69
4.22
3.28
4.35
3.36
3.48
3.71
3.54
4.65
5.81
6.48
Market Cap
725.87M
555.21M
847.17M
635.74M
805.27M
593.99M
581.36M
583.21M
534.24M
670.10M
806.59M
855.24M
Enterprise Value
728.37M
557.28M
840.50M
644.79M
806.63M
588.29M
581.87M
589.18M
544.81M
674.16M
809.39M
837.77M
Calculated Values
Free Cash Flow TTM
-7.93M
-5.55M
-9.09M
-3.63M
-5.75M
-20.25M
-22.92M
-25.22M
-25.98M
-22.83M
-26.51M
-31.56M
Net Debt
2.50M
2.06M
-6.67M
9.05M
1.36M
-5.71M
504.00K
5.97M
10.57M
4.07M
2.79M
-17.47M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
PEG Ratio
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
EV Revenue TTM
EV FCF TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of data

Insider Transactions

2026-06-05Sale
Owner: Dunn, Jeffrey W
Title: -
Shares: 3,575
Price/Share: $15.25
Value: $54,518.75
Shares Owned: 16,057
Relationship: Director
Ownership: Direct
2026-05-29Sale
Owner: Davis, Timothy E Jr
Title: -
Shares: 3,500
Price/Share: $14.14
Value: $49,490.00
Shares Owned: 65,722
Relationship: Director
Ownership: Direct
2026-05-18Sale
Owner: Maheshwari, Anshul
Title: Chief Financial Officer
Shares: 4,666
Price/Share: $14.68
Value: $68,496.88
Shares Owned: 259,877
Relationship: Officer
Ownership: Direct
2026-05-18Sale
Owner: Francis, Laura
Title: Chief Executive Officer
Shares: 14,957
Price/Share: $14.69
Value: $219,718.33
Shares Owned: 503,444
Relationship: Director,Officer
Ownership: Direct
2026-05-18Sale
Owner: Pisetsky, Michael A.
Title: SVP, Ops & Adm/Chief Legal Ofr
Shares: 3,726
Price/Share: $14.64
Value: $54,548.64
Shares Owned: 280,509
Relationship: Officer
Ownership: Direct

Subscribe to unlock 17+ years of data

Institutional Ownership

No data available for chart
2026-03-31
96.37%
Inst. Shares: 42,363,216
Shares Outstanding: 43,959,760
2025-12-31
93.46%
Inst. Shares: 40,149,417
Shares Outstanding: 42,959,856
2025-09-30
94.30%
Inst. Shares: 40,726,434
Shares Outstanding: 43,188,524
2025-06-30
91.80%
Inst. Shares: 39,280,335
Shares Outstanding: 42,788,123
2025-03-31
93.18%
Inst. Shares: 39,451,667
Shares Outstanding: 42,337,481

SI-BONE, Inc. (SIBN) — SEC Financial Statements & Analysis

SI-BONE, Inc. (SIBN) is a surgical & medical instruments & apparatus company, incorporated in DE. SI-BONE, Inc. trades on Nasdaq as: SIBN. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), SI-BONE, Inc. reported a 15.30% year-over-year revenue growth, a Gross Profit Margin of 79.53% (TTM), a Debt-to-Equity ratio of 0.36x, a Price-to-Sales (P/S) ratio of 3.40x (TTM), a Price-to-Book (P/B) ratio of 3.98x (TTM), at a market cap of $725.87M. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y
15.30%
Gross Profit Margin TTM
79.53%
Debt To Equity
0.36x
P/S TTM
3.40x
P/B TTM
3.98x
Market Cap
$725.87M

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is SI-BONE, Inc. in?

SI-BONE, Inc. (SIBN) operates in the Surgical & Medical Instruments & Apparatus industry.

What is SIBN's market cap?

SI-BONE, Inc. (SIBN) has a market capitalization of $725.87M as of 2026-06-30.

What exchange does SIBN trade on?

SI-BONE, Inc. (SIBN) trades on the Nasdaq.

Where is SI-BONE, Inc. incorporated?

SI-BONE, Inc. is incorporated in DE.

Wall Street's data.
Main Street's price.